Clinical Roundup Different KRAS mutations affect how tumors interact with the immune system, UTSW-led study finds February 20, 2026Vol.52 No.07
Clinical Roundup Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds February 20, 2026Vol.52 No.07
Drugs & Targets FDA grants Breakthrough Therapy designation to Rybrevant Faspro in advanced head-and-neck cancer February 20, 2026Vol.52 No.07
Drugs & Targets Siemens Healthineers and Mayo Clinic collaborate to improve care for neurodegenerative disease, cancer February 20, 2026Vol.52 No.07
Drugs & Targets PharmaMar, Globant collaborate to accelerate oncology research with AI February 20, 2026Vol.52 No.07
NCI The FY26 funding package gave NCI a raise, but the institute’s buying power is 18% less than it was two decades agoLowy: “We still have percentiles, but we’re not allowed to make awards exclusively on the basis of payline.” February 13, 2026Vol.52 No.06By Jacquelyn Cobb
Regulatory News CBER Director Vinay Prasad sidelined staff to jettison Moderna’s mRNA flu shot February 13, 2026Vol.52 No.06By Claire Marie Porter
NCI NCAB ad hoc group approves seven new, reissue concepts February 13, 2026Vol.52 No.06By Sara Willa Ernst
